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polyneuropathy in Scandinavian Alaskan 
malamute dogs—old enemy or new entity? A 
case series
Karin Hultin Jäderlund1* , Cecilia Rohdin2,3, Mette Berendt4, Øyvind Stigen1, Merete Fredholm4, 
Arild Espenes5, Inge Bjerkås5 and Lars Moe1
Abstract 
A homozygous mutation has been identified in the N-myc downstream-regulated gene 1 (NDRG1) in recent cases 
of polyneuropathy in Alaskan malamute dogs from the Nordic countries and USA. The objective of the present 
study was to determine if cases diagnosed 30–40 years ago with polyneuropathy in the Alaskan malamute breed in 
Norway had the same hereditary disease as the recent cases. Fourteen historical cases and 12 recently diagnosed 
Alaskan malamute dogs with hereditary polyneuropathy, and their parents and littermates (n = 88) were included in 
this study (total n = 114). After phenotyping of historical and recent cases, NDRG1 genotyping was performed using 
DNA extracted from archived material from five Norwegian dogs affected by the disease in the late 1970s and 1980s. 
In addition, pedigrees were analysed. Our study concluded that historical and recent phenotypic polyneuropathy 
cases were carrying the same NDRG1-mutation. The pedigree analysis showed that all affected Alaskan malamute 
cases with polyneuropathy could be traced back to one common ancestor of North American origin. By this study, a 
well-documented example of the silent transmission of recessive disease-causing alleles through many generations is 
provided, demonstrated by the re-emergence of a phenotypically and genetically uniform entity in the Scandinavian 
Alaskan malamute population.
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Findings
Degenerative polyneuropathies in dog breeds were 
reviewed in 2011 [1]. For most breeds, the disorder was 
considered inherited, with a breed-specific phenotype. 
Charcot-Marie-Tooth disease (CMT) constitutes the 
corresponding group of inherited polyneuropathies in 
humans. Common for canine polyneuropathies and the 
CMTs are dysfunctional peripheral nerves. The subtypes 
of inherited polyneuropathies may differ in characteristic 
details, e.g. clinical course, nerve fibre types involved, 
mode of inheritance and underlying gene mutation.
Some genetic aetiologies for canine polyneuropathies 
have recently been identified [2–6]. In humans, 80 dif-
ferent genes have been associated with CMT [7]. Some 
CMT-causing mutations are associated with considerable 
phenotypic variability and, conversely, a specific neuro-
logic phenotype can apparently be caused by mutations 
in different genes, as also described in a canine breed [5, 
8–10]. These confusing genotype-phenotype relation-
ships are poorly understood, but might result from modi-
fying genes, epigenetics or environments.
A hereditary polyneuropathy in the Alaskan malamute 
(HPAM) population in Norway, with an autosomal reces-
sive mode of inheritance, was reported in the 1980s [11–
13]. After advice from the researchers, the Norwegian 
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Alaskan malamute (AM) club initiated a breeding strat-
egy to exclude obligate or probable carrier dogs from 
breeding, and thereafter no cases were diagnosed for 
more than 20  years. However, recently cases of HPAM 
recurred in Scandinavia. In 2013, recent HPAM cases 
from the Nordic countries and USA were reported to be 
homozygous for a mutation in the N-myc downstream-
regulated gene 1 (NDRG1) [4].
Breeding strategies against recessively inherited canine 
diseases purely based on phenotypic characteristics have 
also failed previously, e.g. as with the fox terrier heredi-
tary ataxia [14] since, inadvertently, carrier animals can 
go undetected in the population. Nonetheless, based 
on phenotypic similarities one cannot decide whether 
the recurring entity is the same disease genetically. Fur-
thermore, even if the same genotype was confirmed in 
affected animals from different periods, it is best to prove 
that the mutated allele has been transmitted silently 
through the generations by identifying a common ances-
tor for all affected cases, if possible. The alternative would 
be that a separate mutation had occurred in the same 
locus in parallel in another founder—while feasible, this 
is extremely unlikely.
Thus, one aim of the present study was to investigate 
if the genotype in archived tissue from historical Norwe-
gian HPAM cases was the same as the genotype found 
in recent Scandinavian cases. We also aimed at linking 
the families of historical and recent Scandinavian cases 
together by pedigree analysis.
Altogether, 114 privately owned AM dogs were 
included in this case series. A total of eight historical 
DNA samples were available (only seven ultimately pro-
vided useable DNA for NDRG1 testing); DNA samples 
from 21 recent dogs were previously NDRG1 tested. 
Forty-one historical dogs were included in the pedigree 
only (they were not NDRG1 tested) and of those, clinical 
information allowing a diagnosis of polyneuropathy was 
available for nine dogs. No ethics approval was required 
as samples were collected in accordance with the insti-
tutional guidelines for animal welfare and ethics and all 
diagnostic procedures and samplings would anyway have 
been carried out as part of the normal clinical diagnostics 
in affected animals.
Fourteen historical AM dogs with a clinical diagnosis of 
polyneuropathy, born in Norway from 1975 to 1983, were 
investigated (Fig. 1). Information characterizing the his-
torical dogs was retrieved from archived clinical records, 
pedigrees, photos, histopathological specimens, electron 
microscopy images and images from muscle histochem-
istry. One of the authors (LM) had examined all histori-
cal cases clinically and neurologically at the Norwegian 
School of Veterinary Science (NVH). Predominant clini-
cal signs were exercise intolerance, inspiratory stridor 
and pelvic limb ataxia. Nine of the cases were necropsied 
at NVH by one of the authors (IB). For the genotyping, 
archived formalin-fixed paraffin-embedded (FFPE) tissue 
blocks from six affected dogs were available.
In addition, archived information about all littermates 
(n  =  27) and parents (n  =  7) of the affected historical 
dogs were scrutinized. Four parents and four littermates 
had been examined at NVH, none of these showed signs 
of polyneuropathy. According to breeders and owners 
at that time, the other littermates (n =  23) and parents 
(n = 3) also appeared unaffected. For additional genotyp-
ing of historical material, archived frozen semen from 
one unaffected littermate and FFPE tissue blocks from 
another unaffected littermate were available. Both these 
dogs belonged to the group of littermates that were clini-
cally examined at NVH.
Twelve affected recent dogs, born from 2001 to 2013, 
were from Norway (n = 9), Sweden (n = 2) and Denmark 
(n = 1). All had been tested homozygous for the NRDG1-
mutation. Predominant clinical signs were exercise intol-
erance, inspiratory stridor and pelvic limb ataxia. They 
were clinically diagnosed with AM polyneuropathy, 
as described by Bruun et  al. [4]. Five of them were also 
included in that study [4].
Furthermore, we included available information on 
parents and littermates (n = 54) of recent cases. Finally, 
we classified the littermates of all affected dogs as either 
“examined and unaffected” or “unknown clinical status”, 
as well as “heterozygous” or “wild type” for unaffected 
dogs genetically tested (Fig. 1).
Accordingly, tissues from altogether eight historical 
dogs were available for genotyping. DNA was extracted 
from FFPE tissue (n = 7) and frozen semen (n = 1) using 
a commercial purification kit (MasterPure™ DNA Purifi-
cation Kit; Epicentre, Madison, USA) and phenol–chloro-
form extraction respectively. Genotyping was performed 
using a TaqMan assay as described previously [4].
Pedigrees of the recent (n  =  12) and historically 
(n = 14) affected Scandinavian cases were retrieved from 
the Kennel Clubs of Norway, Denmark and Sweden and 
supplemented with ancestral information of relatives 
from the Kennel Clubs of America, Finland, Australia 
and the AM database. Pedigrees were compared, and lin-
eages of both parents of affected dogs were traced back in 
time to the most recent common ancestor.
Extraction of DNA from tissue was successful in five 
historical cases and in the two unaffected littermates. The 
five cases were all homozygous for the NDRG1-muta-
tion. One genotyped littermate was heterozygous and 
the other genotyped littermate was homozygous for the 
wild type allele (Fig.  1). Thereby, we could confirm that 
those historical cases had the same genetic background 
for their disorder as previously reported recent cases [4].
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From the pedigree analyses it appeared that all affected 
dogs, recent and historical, had a North American female 
dog born approximately 1955 as their most recent com-
mon ancestor on both their father’s and their mother’s sides 
(Fig. 1). This points to her (or potentially one of her ances-
tors) as a possible and probable founder of the mutation. 
However, no DNA was available to prove this assumption.
The historical Norwegian and the recent Scandinavian 
HPAM-cases are linked together by having the same gen-
otype and a common ancestry. HPAM, emerging in the 
Scandinavian population of AMs decades apart, should 
be considered one uniform entity. On a more general 
level, this re-emergence of a phenotypically and geneti-
cally uniform entity in the Scandinavian Alaskan mala-
mute population provides a well-documented example of 
the silent transmission of recessive disease-causing alleles 
through many generations.
The breeding strategy by the Norwegian breed club aimed 
to exempt dogs from breeding that: (1) with certainty were 
carriers of the abnormal gene (parents: heterozygotes; and 
affected animals: homozygotes) and (2) to avoid using ani-
mals with a high probability of being carriers; (i.e. siblings 
of affected animals and offspring of parents that earlier had 
produced affected dogs). It was recommended (3) to record 
all information about HPAM status in future offspring and 
(4) to demonstrate a supportive attitude to breeders who 
unintentionally had produced HPAM cases.
The breeding strategy of the Norwegian AM club was 
indeed successful in preventing new cases of HPAM among 
descendants of the families directly involved in the histori-
cal cases (Fig. 1). The return of HPAM in Scandinavia was 
still not surprising, given the mode of inheritance and the 
mobility of dogs between different countries. As recessive 
alleles can be transmitted silently through generations, 
clinically affected
clinically unaffected
male, female, unknown sex; unknown disease status
clinically affected, tested homozygous
clinically unaffected, tested wt/wt
clinically unaffected, tested heterozygous
Fig. 1 A schematic pedigree of Alaskan malamute dogs affected by hereditary polyneuropathy. A schematic pedigree of historical Norwegian and 
recent Scandinavian Alaskan malamute dogs affected by hereditary polyneuropathy, showing that both parents of all affected dogs are descending 
from one common ancestor. The families of historical dogs have a shaded background in the figure. Genotyped dogs are indicated as homozygous 
or heterozygous for the NDRG1-mutation, or homozygous wild type (wt/wt). Dogs that are neither affected nor genotyped are classified as either 
clinically unaffected or with unknown disease status. The mother of a test-mating litter of the historical dogs was inseminated. By accident, one 
straw of semen from another dog than the one meant to be father was used together with straws from the intended male, which is shown as two 
fathers for that specific litter in the figure. Black arrow points at common ancestor, born approximately 1955
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unintentional mating of heterozygotes to each other, result-
ing in affected homozygotes, was to be anticipated. The 
disease-causing mutation seems to have segregated in the 
breed for at least 60 years and, on a world-wide basis, obvi-
ously there were other lineages in parallel in this breed, 
transmitting the mutation in the 1970s and 1980s.
A breeding strategy like the one applied in Norway for 
HPAM puts a negative pressure on the total gene pool of 
the involved population. By narrowing the gene pool in a 
breed, there is a risk of more breed-related health prob-
lems as a consequence to increasing frequency of other 
defective genes. For HPAM, a genetic test is now avail-
able [4] and is useful for identification of carriers of the 
disease. By this reliable new tool, strategic use of het-
erozygous individuals for breeding, and eventually eradi-
cation of the mutation from the breed is possible.
In conclusion, HPAM is an inherited autosomal reces-
sive disease, caused by the same mutation in the NDRG1 
in historical and recent Scandinavian cases.
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